The ex vivo study demonstrated that TNF-α or IL-1β stimulation on PBMCs from our active RA patients resulted in significantly enhanced levels of MDL-1 expression when compared to those from OA patients or from healthy control subjects. Here, IL1B is linked to rheumatoid arthritis.